3 unknown, 2 not yet recruiting, 1 active not recruiting, 1 recruiting. 8 Not applicable.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 8 | Unknown 3, Not yet recruiting 2, Active not recruiting 1, Recruiting 1, Terminated 1 |
Follow Transarterial Chemoembolization: new trials by email Literature Review of Transarterial Chemoembolization trials Research Report on Transarterial Chemoembolization
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Low-Dose Bevacizumab and Atezolizumab Combined With TACE-HAIC in Unresectable Hepatocellular Carcinoma TACE-HAIC + Atezolizumab + Low-dose Bevacizumab - Hepatocellular Carcinoma, Atezolizumab Plus Bevacizumab | Not applicable | Not yet recruiting | Third Affiliated Hospital, Sun Yat-Sen University | 38 | 2026-05-01 | 2026-04-22 |
| Transarterial Chemoembolization With Low-Dose Bevacizumab Plus Atezolizumab as First-Line Treatment for Unresectable Hepatocellular Carcinoma Transarterial chemoembolization (TACE), bevacizumab and atezolizumab - Hepatocellular Carcinoma, Transarterial Chemoembolization | Not applicable | Not yet recruiting | Third Affiliated Hospital, Sun Yat-Sen University | 30 | 2026-01-01 | 2025-12-15 |
| qDSA Blood Flow Measurement in Patients Undergoing TAE of the Liver qDSA Blood Flow Measurement - Transarterial Embolism, Transarterial Chemoembolization | Not applicable | Recruiting | University of Wisconsin, Madison | 20 | 2025-03-13 | 2026-09-15 |
| Effectiveness of Enhanced Web-Based Health Education on Self-Care Practices and Quality of Life Among Patients With Hepatocellular Carcinoma Undergoing TACE Enhanced Web-Based Health Education, Routine Health Education - Transarterial Chemoembolization, TACE(Transcatheter Arterial Chemoembolization) | Not applicable | Active not recruiting | University Medical Center Ho Chi Minh City (UMC) | 252 | 2024-09-13 | 2026-09-17 |
| Effects of Antrodia Cinnamomea on the Hepatoma Patients After Transcatheter Hepatic Artery Chemoembolization Antrodia cinnamomea, placebo - Hepatocellular Carcinoma, Transarterial Chemoembolization | Not applicable | Terminated | Taichung Tzu Chi Hospital | 23 | 2023-01-01 | 2026-10-06 |
| TACE-HAIC Plus Lenvatinib for Patients With Unresectable HCC: an Open-label, Single-arm, Phase 2 Trial TACE-HAIC plus lenvatinib - Hepatocellular Carcinoma, Transarterial Chemoembolization | Not applicable | Unknown | Yunfei Yuan | 60 | 2020-10-11 | 2021-09-22 |
| Microwave Ablation Combined With TACE in the Treatment of Unresectable Huge Hepatocellular Carcinoma Huge TACE, MWA, MWA system - Hepatocellular Carcinoma Non-resectable, Transarterial Chemoembolization | Not applicable | Unknown | Fan Weijun | 100 | 2017-12-01 | 2019-05-07 |
| Survival According to the Feeding Artery Obliteration by Chemoembolization for Unresectable Hepatocellular Carcinoma Intermediate embolization, Complete embolization - Hepatocellular Carcinoma, Transarterial Chemoembolization | Not applicable | Unknown | Hallym University Medical Center | 250 | 2012-08-01 | 2012-09-03 |
Adenocarcinoma (6) · Carcinoma (6) · Digestive System Diseases (6) · Digestive System Neoplasms (6) · Liver Diseases (6) · Liver Neoplasms (6) · Neoplasms (6) · Neoplasms by Histologic Type (6) · Neoplasms by Site (6) · Neoplasms, Glandular and Epithelial (6)
Bevacizumab (2) · atezolizumab (2) · Chemoembolization, Therapeutic (1) · Doxorubicin (1) · Gelatin Sponge, Absorbable (1) · lenvatinib (1)
Third Affiliated Hospital, Sun Yat-Sen University (2) · Fan Weijun (1) · Hallym University Medical Center (1) · Taichung Tzu Chi Hospital (1) · University Medical Center Ho Chi Minh City (UMC) (1) · University of Wisconsin, Madison (1) · Yunfei Yuan (1)
China (2) · South Korea (1) · Taiwan (1) · United States (1) · Vietnam (1)
Mingsheng Huang, M.D. & Ph.D (1) · Paul Laeseke, MD, PhD (1) · Sang Hoon Park, M.D., Ph.D. (1) · Weijun Fan, M.D (1)
PMID 11858978, PMID 30082086, PMID 31989907, PMID 34801630, PMID 35294089